Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodes 16-30 of 461
Identifying Mpox Hospitalization Risks in Patients with HIV During the 2022 Outbreak
Clinician's RoundtableIdentifying Mpox Hospitalization Risks in Patients with HIV During the 2022 Outbreak
Awareness During Intubation: Exploring Risks and Monitoring in ICU Settings
Clinician's RoundtableAwareness During Intubation: Exploring Risks and Monitoring in ICU Settings
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living RheumExploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living RheumCadherin-6 in Focus: Existing Antibodies, Emerging Applications
Obesity and Respiratory Function: Understanding Mechanical and Functional Impacts
Clinician's RoundtableObesity and Respiratory Function: Understanding Mechanical and Functional Impacts
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsultTYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
- advertisement
Identifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Clinician's RoundtableIdentifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Advancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
Clinician's RoundtableAdvancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
Rising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
Clinician's RoundtableRising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiersLUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiersAdvancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiersExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
- advertisement
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular HealthOvercoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular HealthEvaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
